glp 1 weight loss indication GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Weight Loss Specialist in

GLP-1 injections contain real medications such as semaglutide and tirzepatide

Needle phobia affects an estimated 20-30% of the adult population, and the logistics of cold-chain storage, injection site management, and weekly self-administration limit the reach of these therapies to a fraction of the eligible patient population

They also trigger the release of insulin from the pancreas and inhibit the secretion of glucagon, a hormone that raises blood sugar levels

These injections can either be administered by a medical professional or be self-administered and will start on a very low dosage, slowly increasing in amount each month before reaching the target dose to ensure no severe reaction to the medication occurs